175 related articles for article (PubMed ID: 34853284)
1. Identification of the Inhibitory Compounds for Metallo-β-lactamases and Structural Analysis of the Binding Modes.
Kamo T; Kuroda K; Kondo S; Hayashi U; Fudo S; Yoneda T; Takaya A; Nukaga M; Hoshino T
Chem Pharm Bull (Tokyo); 2021; 69(12):1179-1183. PubMed ID: 34853284
[TBL] [Abstract][Full Text] [Related]
2. Development of Inhibitory Compounds for Metallo-beta-lactamase through Computational Design and Crystallographic Analysis.
Kamo T; Kuroda K; Nimura S; Guo Y; Kondo S; Nukaga M; Hoshino T
Biochemistry; 2024 May; 63(10):1278-1286. PubMed ID: 38690676
[TBL] [Abstract][Full Text] [Related]
3. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach.
Muteeb G; Alsultan A; Farhan M; Aatif M
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209073
[TBL] [Abstract][Full Text] [Related]
4. Discovery of the Novel Inhibitor Against New Delhi Metallo-β-Lactamase Based on Virtual Screening and Molecular Modelling.
Wang X; Yang Y; Gao Y; Niu X
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443639
[TBL] [Abstract][Full Text] [Related]
5. Discovery of potential inhibitors against New Delhi metallo-β-lactamase-1 from natural compounds: in silico-based methods.
Salari-Jazi A; Mahnam K; Sadeghi P; Damavandi MS; Faghri J
Sci Rep; 2021 Jan; 11(1):2390. PubMed ID: 33504907
[TBL] [Abstract][Full Text] [Related]
6. Fluorinated captopril analogues inhibit metallo-β-lactamases and facilitate structure determination of NDM-1 binding pose.
Kondratieva A; Palica K; Frøhlich C; Hovd RR; Leiros HS; Erdelyi M; Bayer A
Eur J Med Chem; 2024 Feb; 266():116140. PubMed ID: 38242072
[TBL] [Abstract][Full Text] [Related]
7. High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1.
Rehman MT; AlAjmi MF; Hussain A; Rather GM; Khan MA
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769822
[TBL] [Abstract][Full Text] [Related]
8. Structure-guided optimization of D-captopril for discovery of potent NDM-1 inhibitors.
Ma G; Wang S; Wu K; Zhang W; Ahmad A; Hao Q; Lei X; Zhang H
Bioorg Med Chem; 2021 Jan; 29():115902. PubMed ID: 33302045
[TBL] [Abstract][Full Text] [Related]
9. Probing the Interaction of Aspergillomarasmine A with Metallo-β-lactamases NDM-1, VIM-2, and IMP-7.
Bergstrom A; Katko A; Adkins Z; Hill J; Cheng Z; Burnett M; Yang H; Aitha M; Mehaffey MR; Brodbelt JS; Tehrani KHME; Martin NI; Bonomo RA; Page RC; Tierney DL; Fast W; Wright GD; Crowder MW
ACS Infect Dis; 2018 Feb; 4(2):135-145. PubMed ID: 29091730
[TBL] [Abstract][Full Text] [Related]
10. Efforts towards the inhibitor design for New Delhi metallo-beta-lactamase (NDM-1).
Nagulapalli Venkata KC; Ellebrecht M; Tripathi SK
Eur J Med Chem; 2021 Dec; 225():113747. PubMed ID: 34391033
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and in vitro and biological evaluation of potent amino acid-derived thiol inhibitors of the metallo-β-lactamase IMP-1.
Arjomandi OK; Hussein WM; Vella P; Yusof Y; Sidjabat HE; Schenk G; McGeary RP
Eur J Med Chem; 2016 May; 114():318-27. PubMed ID: 27017264
[TBL] [Abstract][Full Text] [Related]
12. Structural insights into the design of reversible fluorescent probes for metallo-β-lactamases NDM-1, VIM-2, and IMP-1.
Price S; Mehta R; Tan D; Hinojosa A; Thomas PW; Cummings T; Fast W; Que EL
J Inorg Biochem; 2022 Aug; 233():111869. PubMed ID: 35653820
[TBL] [Abstract][Full Text] [Related]
13. Fragment-based discovery of inhibitor scaffolds targeting the metallo-β-lactamases NDM-1 and VIM-2.
Christopeit T; Leiros HK
Bioorg Med Chem Lett; 2016 Apr; 26(8):1973-7. PubMed ID: 26976213
[TBL] [Abstract][Full Text] [Related]
14. Potential inhibitors designed against NDM-1 type metallo-β-lactamases: an attempt to enhance efficacies of antibiotics against multi-drug-resistant bacteria.
Khan AU; Ali A; Danishuddin ; Srivastava G; Sharma A
Sci Rep; 2017 Aug; 7(1):9207. PubMed ID: 28835636
[TBL] [Abstract][Full Text] [Related]
15. 4-Amino-1,2,4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitors.
Gavara L; Sevaille L; De Luca F; Mercuri P; Bebrone C; Feller G; Legru A; Cerboni G; Tanfoni S; Baud D; Cutolo G; Bestgen B; Chelini G; Verdirosa F; Sannio F; Pozzi C; Benvenuti M; Kwapien K; Fischer M; Becker K; Frère JM; Mangani S; Gresh N; Berthomieu D; Galleni M; Docquier JD; Hernandez JF
Eur J Med Chem; 2020 Dec; 208():112720. PubMed ID: 32937203
[TBL] [Abstract][Full Text] [Related]
16. Aurones and derivatives as promising New Delhi metallo-β-lactamase (NDM-1) inhibitors.
Caburet J; Verdirosa F; Moretti M; Roulier B; Simoncelli G; Haudecoeur R; Ghazi S; Jamet H; Docquier JD; Boucherle B; Peuchmaur M
Bioorg Med Chem; 2024 Jan; 97():117559. PubMed ID: 38109811
[TBL] [Abstract][Full Text] [Related]
17. Investigation of Dipicolinic Acid Isosteres for the Inhibition of Metallo-β-Lactamases.
Chen AY; Thomas PW; Cheng Z; Xu NY; Tierney DL; Crowder MW; Fast W; Cohen SM
ChemMedChem; 2019 Jul; 14(13):1271-1282. PubMed ID: 31124602
[TBL] [Abstract][Full Text] [Related]
18. Structural studies of triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-β-lactamases.
Muhammad Z; Skagseth S; Boomgaren M; Akhter S; Fröhlich C; Ismael A; Christopeit T; Bayer A; Leiros HS
Bioorg Med Chem; 2020 Aug; 28(15):115598. PubMed ID: 32631568
[TBL] [Abstract][Full Text] [Related]
19. Structural and biochemical analysis of the metallo-β-lactamase L1 from emerging pathogen Stenotrophomonas maltophilia revealed the subtle but distinct di-metal scaffold for catalytic activity.
Kim Y; Maltseva N; Wilamowski M; Tesar C; Endres M; Joachimiak A
Protein Sci; 2020 Mar; 29(3):723-743. PubMed ID: 31846104
[TBL] [Abstract][Full Text] [Related]
20. A close look onto structural models and primary ligands of metallo-β-lactamases.
Raczynska JE; Shabalin IG; Minor W; Wlodawer A; Jaskolski M
Drug Resist Updat; 2018 Sep; 40():1-12. PubMed ID: 30466711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
